Filana Therapeutics, Inc. (FLNA) stock
FLNANasdaqPharmaceutical PreparationsFiscal year ends December 31
$0.64+0.08 (+14.52%)
Close on Nov 20, 2026Market cap $30.98MP/E –Yield –
Filana Therapeutics operating margin
Operating margin is operating income as a percentage of revenue.
For fiscal 2013 it was 76.3%, against -35.8% the year before. The highest annual figure on record is 76.3% in fiscal 2013.
Annual operating margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2013 | Dec 31, 2013 | 76.3% | +112.1 |
| FY2012 | Dec 31, 2012 | -35.8% | −5.2 |
| FY2011 | Dec 31, 2011 | -30.6% | +50.9 |
| FY2010 | Dec 31, 2010 | -81.5% | −48.7 |
| FY2009 | Dec 31, 2009 | -32.8% | – |
See a number that looks wrong?